
Please try another search
Apontis Pharma AG engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany. It offers single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, hyperlipidemia, and secondary prophylaxis, as well as respiratory diseases and diabetes. The company was founded in 1946 and is based in Monheim am Rhein, Germany. As of November 21, 2024, Apontis Pharma AG operates as a subsidiary of Zentiva AG.
Name | Age | Since | Title |
---|---|---|---|
Matthias Wiedenfels | 49 | 2022 | Independent Chairman of Supervisory Board |
Olaf Elbracht | 57 | 2022 | Independent Deputy Chairman of Supervisory Board |
Anant Atal | - | 2024 | Member of the Supervisory Board |
Martin Albert | - | 2024 | Member of the Supervisory Board |
Julie Ross | - | 2024 | Member of the Supervisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review